Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 4
2007 3
2008 3
2009 3
2010 5
2011 5
2012 1
2013 3
2015 1
2016 3
2017 3
2018 3
2019 4
2020 4
2021 6
2022 5
2023 5
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd).
Tsao LC, Wang JS, Ma X, Sodhi S, Ragusa JV, Liu B, McBane J, Wang T, Wei J, Liu CX, Yang X, Lei G, Spasojevic I, Fan P, Trotter TN, Morse M, Lyerly HK, Hartman ZC. Tsao LC, et al. Among authors: hartman zc. Nat Commun. 2025 Apr 2;16(1):3167. doi: 10.1038/s41467-025-58266-8. Nat Commun. 2025. PMID: 40175391 Free PMC article.
Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancer.
Tinoco JC, Saunders HI, Werner LR, Sun X, Chowanec EI, Heard A, Chalise P, Vahrenkamp JM, Wilson AE, Liu CX, Lei G, Wei J, Cros H, Mohammed H, Troester M, Perou C, Markiewicz MA, Gertz J, Balko JM, Hartman ZC, Hagan CR. Tinoco JC, et al. Among authors: hartman zc. J Immunother Cancer. 2025 Mar 18;13(3):e010179. doi: 10.1136/jitc-2024-010179. J Immunother Cancer. 2025. PMID: 40102028 Free PMC article.
Vaccines targeting ESR1 activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancer.
Dailey GP, Rabiola CA, Lei G, Wei J, Yang XY, Wang T, Liu CX, Gajda M, Hobeika AC, Summers A, Marek RD, Morse MA, Lyerly HK, Crosby EJ, Hartman ZC. Dailey GP, et al. Among authors: hartman zc. Hum Vaccin Immunother. 2024 Dec 31;20(1):2309693. doi: 10.1080/21645515.2024.2309693. Epub 2024 Feb 8. Hum Vaccin Immunother. 2024. PMID: 38330990 Free PMC article.
CEA vaccines.
Bhagat A, Lyerly HK, Morse MA, Hartman ZC. Bhagat A, et al. Among authors: hartman zc. Hum Vaccin Immunother. 2023 Dec 15;19(3):2291857. doi: 10.1080/21645515.2023.2291857. Epub 2023 Dec 13. Hum Vaccin Immunother. 2023. PMID: 38087989 Free PMC article. Review.
Clinical trials of self-replicating RNA-based cancer vaccines.
Morse MA, Crosby EJ, Force J, Osada T, Hobeika AC, Hartman ZC, Berglund P, Smith J, Lyerly HK. Morse MA, et al. Among authors: hartman zc. Cancer Gene Ther. 2023 Jun;30(6):803-811. doi: 10.1038/s41417-023-00587-1. Epub 2023 Feb 10. Cancer Gene Ther. 2023. PMID: 36765179 Free PMC article. Review.
Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers.
Kaneko K, Acharya CR, Nagata H, Yang X, Hartman ZC, Hobeika A, Hughes PF, Haystead TAJ, Morse MA, Lyerly HK, Osada T. Kaneko K, et al. Among authors: hartman zc. J Immunother Cancer. 2022 Sep;10(9):e004793. doi: 10.1136/jitc-2022-004793. J Immunother Cancer. 2022. PMID: 36171008 Free PMC article.
57 results